Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis

Filippo Vurro, Lucia Merolle, Chiara Marraccini, Maura Parisi, Laura Canovi, Barbara Erta, Annalisa Santachiara, Laura Bonvicini, Paolo Giorgi Rossi, Roberto Baricchi, Thelma A. Pertinhez

Research output: Contribution to journalArticle

Abstract

BACKGROUND: To date, the quantification of the anticoagulant (ACD-A) in plasma units has been based on theoretical calculations. An accurate quantification could help minimize the risks associated with plasmapheresis, given that the total ACD-A used during the procedure is distributed between the donor and the plasma unit. Our aim was to experimentally quantify the volume of ACD-A in units collected by plasmapheresis. STUDY DESIGN AND METHODS: We used proton nuclear magnetic resonance spectroscopy to measure the ACD-A volume in 295 plasma units collected by the Azienda USL-IRCCS of Reggio Emilia, Italy. We analyzed the determinants of the differences between estimated and measured ACD-A through multivariate regression models. RESULTS: The experimentally measured ACD-A in plasma units was variable, with 45% of the samples showing a discrepancy of more than 15 mL compared to the manufacturer's estimate. ACD-A was underestimated for higher density of the units (p < 0.0005); a weak association was also observed with triglycerides (underestimated for higher levels, p = 0.015) and sex (overestimated in females, p = 0.008), but our model explained only 35% of the individual variability. CONCLUSION: The manufacturer's algorithms do not accurately estimate the ACD-A in units collected by plasmapheresis. Donor-related characteristics may affect ACD-A distribution between donor and plasma unit, thereby explaining the discrepancies between estimate and measurement. Errors in the estimate of the ACD-A actually received by donors could hamper studies on dose–response relationship between anticoagulant and adverse reactions. Our work should stimulate research on tailored procedures aimed at minimizing the anticoagulant received by donors and increasing plasmapheresis safety.

Original languageEnglish
Pages (from-to)2113-2120
Number of pages8
JournalTransfusion
Volume59
Issue number6
DOIs
Publication statusPublished - Jun 1 2019

Fingerprint

Plasmapheresis
Anticoagulants
Italy
Triglycerides
Magnetic Resonance Spectroscopy
Safety
Research

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Hematology

Cite this

Vurro, F., Merolle, L., Marraccini, C., Parisi, M., Canovi, L., Erta, B., ... Pertinhez, T. A. (2019). Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis. Transfusion, 59(6), 2113-2120. https://doi.org/10.1111/trf.15244

Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis. / Vurro, Filippo; Merolle, Lucia; Marraccini, Chiara; Parisi, Maura; Canovi, Laura; Erta, Barbara; Santachiara, Annalisa; Bonvicini, Laura; Giorgi Rossi, Paolo; Baricchi, Roberto; Pertinhez, Thelma A.

In: Transfusion, Vol. 59, No. 6, 01.06.2019, p. 2113-2120.

Research output: Contribution to journalArticle

Vurro, F, Merolle, L, Marraccini, C, Parisi, M, Canovi, L, Erta, B, Santachiara, A, Bonvicini, L, Giorgi Rossi, P, Baricchi, R & Pertinhez, TA 2019, 'Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis', Transfusion, vol. 59, no. 6, pp. 2113-2120. https://doi.org/10.1111/trf.15244
Vurro F, Merolle L, Marraccini C, Parisi M, Canovi L, Erta B et al. Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis. Transfusion. 2019 Jun 1;59(6):2113-2120. https://doi.org/10.1111/trf.15244
Vurro, Filippo ; Merolle, Lucia ; Marraccini, Chiara ; Parisi, Maura ; Canovi, Laura ; Erta, Barbara ; Santachiara, Annalisa ; Bonvicini, Laura ; Giorgi Rossi, Paolo ; Baricchi, Roberto ; Pertinhez, Thelma A. / Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis. In: Transfusion. 2019 ; Vol. 59, No. 6. pp. 2113-2120.
@article{b58f53b091b34d1fac20489b6d82edda,
title = "Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis",
abstract = "BACKGROUND: To date, the quantification of the anticoagulant (ACD-A) in plasma units has been based on theoretical calculations. An accurate quantification could help minimize the risks associated with plasmapheresis, given that the total ACD-A used during the procedure is distributed between the donor and the plasma unit. Our aim was to experimentally quantify the volume of ACD-A in units collected by plasmapheresis. STUDY DESIGN AND METHODS: We used proton nuclear magnetic resonance spectroscopy to measure the ACD-A volume in 295 plasma units collected by the Azienda USL-IRCCS of Reggio Emilia, Italy. We analyzed the determinants of the differences between estimated and measured ACD-A through multivariate regression models. RESULTS: The experimentally measured ACD-A in plasma units was variable, with 45{\%} of the samples showing a discrepancy of more than 15 mL compared to the manufacturer's estimate. ACD-A was underestimated for higher density of the units (p < 0.0005); a weak association was also observed with triglycerides (underestimated for higher levels, p = 0.015) and sex (overestimated in females, p = 0.008), but our model explained only 35{\%} of the individual variability. CONCLUSION: The manufacturer's algorithms do not accurately estimate the ACD-A in units collected by plasmapheresis. Donor-related characteristics may affect ACD-A distribution between donor and plasma unit, thereby explaining the discrepancies between estimate and measurement. Errors in the estimate of the ACD-A actually received by donors could hamper studies on dose–response relationship between anticoagulant and adverse reactions. Our work should stimulate research on tailored procedures aimed at minimizing the anticoagulant received by donors and increasing plasmapheresis safety.",
author = "Filippo Vurro and Lucia Merolle and Chiara Marraccini and Maura Parisi and Laura Canovi and Barbara Erta and Annalisa Santachiara and Laura Bonvicini and {Giorgi Rossi}, Paolo and Roberto Baricchi and Pertinhez, {Thelma A.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1111/trf.15244",
language = "English",
volume = "59",
pages = "2113--2120",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Blackwell Publishing Inc.",
number = "6",

}

TY - JOUR

T1 - Quantitative assessment of the anticoagulant in plasma units collected by plasmapheresis

AU - Vurro, Filippo

AU - Merolle, Lucia

AU - Marraccini, Chiara

AU - Parisi, Maura

AU - Canovi, Laura

AU - Erta, Barbara

AU - Santachiara, Annalisa

AU - Bonvicini, Laura

AU - Giorgi Rossi, Paolo

AU - Baricchi, Roberto

AU - Pertinhez, Thelma A.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - BACKGROUND: To date, the quantification of the anticoagulant (ACD-A) in plasma units has been based on theoretical calculations. An accurate quantification could help minimize the risks associated with plasmapheresis, given that the total ACD-A used during the procedure is distributed between the donor and the plasma unit. Our aim was to experimentally quantify the volume of ACD-A in units collected by plasmapheresis. STUDY DESIGN AND METHODS: We used proton nuclear magnetic resonance spectroscopy to measure the ACD-A volume in 295 plasma units collected by the Azienda USL-IRCCS of Reggio Emilia, Italy. We analyzed the determinants of the differences between estimated and measured ACD-A through multivariate regression models. RESULTS: The experimentally measured ACD-A in plasma units was variable, with 45% of the samples showing a discrepancy of more than 15 mL compared to the manufacturer's estimate. ACD-A was underestimated for higher density of the units (p < 0.0005); a weak association was also observed with triglycerides (underestimated for higher levels, p = 0.015) and sex (overestimated in females, p = 0.008), but our model explained only 35% of the individual variability. CONCLUSION: The manufacturer's algorithms do not accurately estimate the ACD-A in units collected by plasmapheresis. Donor-related characteristics may affect ACD-A distribution between donor and plasma unit, thereby explaining the discrepancies between estimate and measurement. Errors in the estimate of the ACD-A actually received by donors could hamper studies on dose–response relationship between anticoagulant and adverse reactions. Our work should stimulate research on tailored procedures aimed at minimizing the anticoagulant received by donors and increasing plasmapheresis safety.

AB - BACKGROUND: To date, the quantification of the anticoagulant (ACD-A) in plasma units has been based on theoretical calculations. An accurate quantification could help minimize the risks associated with plasmapheresis, given that the total ACD-A used during the procedure is distributed between the donor and the plasma unit. Our aim was to experimentally quantify the volume of ACD-A in units collected by plasmapheresis. STUDY DESIGN AND METHODS: We used proton nuclear magnetic resonance spectroscopy to measure the ACD-A volume in 295 plasma units collected by the Azienda USL-IRCCS of Reggio Emilia, Italy. We analyzed the determinants of the differences between estimated and measured ACD-A through multivariate regression models. RESULTS: The experimentally measured ACD-A in plasma units was variable, with 45% of the samples showing a discrepancy of more than 15 mL compared to the manufacturer's estimate. ACD-A was underestimated for higher density of the units (p < 0.0005); a weak association was also observed with triglycerides (underestimated for higher levels, p = 0.015) and sex (overestimated in females, p = 0.008), but our model explained only 35% of the individual variability. CONCLUSION: The manufacturer's algorithms do not accurately estimate the ACD-A in units collected by plasmapheresis. Donor-related characteristics may affect ACD-A distribution between donor and plasma unit, thereby explaining the discrepancies between estimate and measurement. Errors in the estimate of the ACD-A actually received by donors could hamper studies on dose–response relationship between anticoagulant and adverse reactions. Our work should stimulate research on tailored procedures aimed at minimizing the anticoagulant received by donors and increasing plasmapheresis safety.

UR - http://www.scopus.com/inward/record.url?scp=85062966809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062966809&partnerID=8YFLogxK

U2 - 10.1111/trf.15244

DO - 10.1111/trf.15244

M3 - Article

VL - 59

SP - 2113

EP - 2120

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 6

ER -